NASDAQ: PTHL
Pheton Holdings Ltd Stock

$2.72-0.08 (-2.86%)
Updated Apr 21, 2025
PTHL Price
$2.72
Fair Value Price
N/A
Market Cap
$38.76M
52 Week Low
$1.32
52 Week High
$6.45
P/E
-52.31x
P/B
6.27x
P/S
125.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$448.20k
Earnings
-$660.59k
Gross Margin
85%
Operating Margin
-142.52%
Profit Margin
-147.4%
Debt to Equity
0.09
Operating Cash Flow
-$775k
Beta
0.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PTHL Overview

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PTHL's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
B
PTHL
Ranked
Unranked of 103

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$7.50A
$22.62A
$13.45A
View Top Medical Device Stocks

Be the first to know about important PTHL news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PTHL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PTHL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PTHL is poor value based on its book value relative to its share price (6.27x), compared to the US Medical Devices industry average (3.74x)
P/B vs Industry Valuation
PTHL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PTHL due diligence checks available for Premium users.

Valuation

PTHL price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-52.31x
Industry
40.34x
Market
27.14x

PTHL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
6.27x
Industry
3.74x
PTHL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PTHL's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PTHL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PTHL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.7M
Liabilities
$538.6k
Debt to equity
0.09
PTHL's short-term assets ($6.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PTHL's short-term assets ($6.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PTHL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
PTHL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PTHL vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PTHL$38.76M-2.86%-52.31x6.27x
APYX$37.04M+0.51%-1.48x2.61x
OMC$35.86M-9.36%-0.27x1.34x
TELAD$35.20M-6.90%-0.67x1.24x
NVNOD$42.44M-1.22%-1.91x1.01x

Pheton Holdings Stock FAQ

What is Pheton Holdings's quote symbol?

(NASDAQ: PTHL) Pheton Holdings trades on the NASDAQ under the ticker symbol PTHL. Pheton Holdings stock quotes can also be displayed as NASDAQ: PTHL.

If you're new to stock investing, here's how to buy Pheton Holdings stock.

What is the 52 week high and low for Pheton Holdings (NASDAQ: PTHL)?

(NASDAQ: PTHL) Pheton Holdings's 52-week high was $6.45, and its 52-week low was $1.32. It is currently -57.83% from its 52-week high and 106.06% from its 52-week low.

How much is Pheton Holdings's stock price per share?

(NASDAQ: PTHL) Pheton Holdings stock price per share is $2.72 today (as of Apr 21, 2025).

What is Pheton Holdings's Market Cap?

(NASDAQ: PTHL) Pheton Holdings's market cap is $38.76M, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pheton Holdings's market cap is calculated by multiplying PTHL's current stock price of $2.72 by PTHL's total outstanding shares of 14,250,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.